Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -127.18 | 35.31 |
PEG Ratio (TTM) | -2.14 | 12.22 |
P/S Ratio (TTM) | 4.06 | 14.57 |
P/B Ratio (TTM) | 2.44 | 18.17 |
P/FCF Ratio (TTM) | 65.68 | 42.17 |
Price to 5YR AVG Earnings Ratio | N/A | 34.96 |
Price to 5YR AVG FCF Ratio | N/A | 60.47 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.62% | 12.53% |
ROE (TTM) | -1.98% | -3.83% |
Net Profit Margin (TTM) | -3.18% | 25.54% |
ROIC 5YR AVG | N/A | 5.37% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 80.66% | -17.69% | N/A |
Revenue | 3.69% | 28.42% | N/A |
Net Income | 80.57% | -18.72% | N/A |
Cash Flow | 146.60% | 10.39% | N/A |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.36 | 1.39 |
Quick Ratio (TTM) | 1.36 | 1.37 |
D/E Ratio (TTM) | 0.11 | 1.18 |
Interest Coverage (TTM) | -3.03 | 33.69 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 0.48 | 9.05 |
LTL to 5YR AVG FCF | N/A | 5.30 |
Shares Outstanding Growth 5YR AVG | N/A | 0.37% |